• There is no FDA-approved companion diagnostic for ROZLYTREK 1
a NTRK gene fusions can be found across multiple additional tumor types.

CRC=colorectal cancer; FDA=US Food and Drug Administration; MASC=mammary analogue secretory carcinoma; NSCLC=non-small cell lung cancer; NTRK=neurotrophic tyrosine receptor kinase.

ROZLYTREK Efficacy in NTRK Fusion-Positive Solid Tumors

Efficacy Across Tumor Types in Patients With NTRK Fusion-Positive Solid Tumors

View systemic efficacy data in patients with NTRK fusion-positive solid tumors, including response rates by tumor type

ROZLYTREK Safety Profile

Safety Profile

Learn about the safety profile of ROZLYTREK

TRK Testing

Testing for NTRK gene fusions

is the only way to identify patients who may benefit from ROZLYTREK 2